Monreal M - Search Results

1

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR. Farge D, et al. Among authors: monreal m. J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070. J Thromb Haemost. 2013. PMID: 23217107 Free article. Review.

2

Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.

Monreal M, Lafoz E, Olive A, del Rio L, Vedia C. Monreal M, et al. Thromb Haemost. 1994 Jan;71(1):7-11. Thromb Haemost. 1994. PMID: 8165649 Clinical Trial.

3

Upper extremity deep venous thrombosis in cancer patients with venous access devices--prophylaxis with a low molecular weight heparin (Fragmin).

Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A. Monreal M, et al. Thromb Haemost. 1996 Feb;75(2):251-3. Thromb Haemost. 1996. PMID: 8815570 Clinical Trial.

4

Platelet count and the risk of bleeding in hospitalized patients with venous thromboembolism starting anticoagulant therapy.

Monreal M, Urrutia A, Marti S, Cuxart A, Roncales J. Monreal M, et al. Haemostasis. 1997 Mar-Apr;27(2):91-8. doi: 10.1159/000217439. Haemostasis. 1997. PMID: 9212357

5

Occult cancer in patients with venous thromboembolism: which patients, which cancers.

Monreal M, Fernandez-Llamazares J, Perandreu J, Urrutia A, Sahuquillo JC, Contel E. Monreal M, et al. Thromb Haemost. 1997 Nov;78(5):1316-8. Thromb Haemost. 1997. PMID: 9408011

6

Venous thromboembolism as first manifestation of cancer.

Monreal M, Prandoni P. Monreal M, et al. Semin Thromb Hemost. 1999;25(2):131-6. doi: 10.1055/s-2007-994914. Semin Thromb Hemost. 1999. PMID: 10357080 Review.

7

Secondary prevention of venous thromboembolism: A role for low-molecular-weight heparin.

Monreal M, Roncales FJ, Ruiz J, Muchart J, Fraile M, Costa J, Hernandez JA. Monreal M, et al. Haemostasis. 1998 Sep-Oct;28(5):236-43. doi: 10.1159/000022437. Haemostasis. 1998. PMID: 10420072 Clinical Trial.

8

Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism.

Monreal M, Lensing AW, Prins MH, Bonet M, Fernández-Llamazares J, Muchart J, Prandoni P, Jiménez JA. Monreal M, et al. J Thromb Haemost. 2004 Jun;2(6):876-81. doi: 10.1111/j.1538-7836.2004.00721.x. J Thromb Haemost. 2004. PMID: 15140120 Free article.

9

Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial.

Piccioli A, Lensing AW, Prins MH, Falanga A, Scannapieco GL, Ieran M, Cigolini M, Ambrosio GB, Monreal M, Girolami A, Prandoni P; SOMIT Investigators Group. Piccioli A, et al. Among authors: monreal m. J Thromb Haemost. 2004 Jun;2(6):884-9. doi: 10.1111/j.1538-7836.2004.00720.x. J Thromb Haemost. 2004. PMID: 15140122 Free article. Clinical Trial.

10

Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study.

Monreal M, Zacharski L, Jiménez JA, Roncales J, Vilaseca B. Monreal M, et al. J Thromb Haemost. 2004 Aug;2(8):1311-5. doi: 10.1111/j.1538-7836.2004.00853.x. J Thromb Haemost. 2004. PMID: 15304036 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

612 results

Search Page